Seagen Inc. Insider Trading for May 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Seagen Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Seagen Inc. for May 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 22 2018 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
May 22 2018 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 3,700 | 0 | 32,205 | 28.5 K to 32.2 K (+12.98 %) |
May 22 2018 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
May 22 2018 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,700 | 0 | 69,800 | 66.1 K to 69.8 K (+5.60 %) |
May 22 2018 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
May 22 2018 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Grant | A | 0.00 | 3,700 | 0 | 21,800 | 18.1 K to 21.8 K (+20.44 %) |
May 22 2018 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
May 22 2018 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Grant | A | 0.00 | 3,700 | 0 | 21,800 | 18.1 K to 21.8 K (+20.44 %) |
May 22 2018 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
May 22 2018 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Grant | A | 0.00 | 3,700 | 0 | 135,750 | 132.1 K to 135.8 K (+2.80 %) |
May 22 2018 | SGEN | SEATTLE GENETICS I ... | GRYSKA DAVID W | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
May 22 2018 | SGEN | SEATTLE GENETICS I ... | GRYSKA DAVID W | Director | Grant | A | 0.00 | 3,700 | 0 | 45,050 | 41.4 K to 45.1 K (+8.95 %) |
May 18 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
May 18 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
May 18 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 56.77 | 3,700 | 210,049 | 45,829,686 | 45.8 M to 45.8 M (+0.01 %) |
May 18 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 56.77 | 3,700 | 210,049 | 5,291,874 | 5.3 M to 5.3 M (+0.07 %) |
May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 6,740 | 74,747 | 56,495 | |
May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 7,776 | 86,236 | 63,235 | |
May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 4,316 | 47,864 | 71,011 | |
May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 54.17 | 6,740 | 365,106 | 687,146 | 693.9 K to 687.1 K (-0.97 %) |
May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 6,740 | 74,747 | 693,886 | 687.1 K to 693.9 K (+0.98 %) |
May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 55.22 | 7,776 | 429,391 | 687,146 | 694.9 K to 687.1 K (-1.12 %) |
May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 7,776 | 86,236 | 694,922 | 687.1 K to 694.9 K (+1.13 %) |
May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 55.75 | 4,316 | 240,617 | 687,146 | 691.5 K to 687.1 K (-0.62 %) |
May 11 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 4,316 | 47,864 | 691,462 | 687.1 K to 691.5 K (+0.63 %) |
May 11 2018 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Option Exercise | M | 16.41 | 7,000 | 114,870 | 892 | |
May 11 2018 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Option Exercise | M | 15.46 | 2,000 | 30,920 | 268 | |
May 11 2018 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Sell | S | 55.33 | 9,000 | 497,983 | 71,831 | 80.8 K to 71.8 K (-11.13 %) |
May 11 2018 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Buy | M | 15.46 | 2,000 | 30,920 | 80,831 | 78.8 K to 80.8 K (+2.54 %) |
May 11 2018 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Buy | M | 16.41 | 7,000 | 114,870 | 78,831 | 71.8 K to 78.8 K (+9.75 %) |
May 08 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 54.02 | 126,399 | 6,828,339 | 45,825,986 | 45.7 M to 45.8 M (+0.28 %) |
May 08 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 53.70 | 129,715 | 6,966,305 | 45,699,587 | 45.6 M to 45.7 M (+0.28 %) |
May 08 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.68 | 204,537 | 10,775,582 | 45,569,872 | 45.4 M to 45.6 M (+0.45 %) |
May 07 2018 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Sell | S | 53.81 | 4,000 | 215,238 | 71,831 | 75.8 K to 71.8 K (-5.27 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 10.08 | 10,000 | 100,800 | 0 | |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 10.08 | 10,000 | 100,800 | 0 | |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 54.42 | 9,105 | 495,488 | 45,365,335 | 45.4 M to 45.4 M (+0.02 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.26 | 21,442 | 1,120,576 | 45,356,230 | 45.3 M to 45.4 M (+0.05 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.33 | 37,400 | 1,957,022 | 45,334,788 | 45.3 M to 45.3 M (+0.08 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.88 | 2,000 | 103,750 | 45,297,388 | 45.3 M to 45.3 M (0.00 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.33 | 5,951 | 311,418 | 45,295,388 | 45.3 M to 45.3 M (+0.01 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.06 | 37,963 | 1,976,213 | 45,289,437 | 45.3 M to 45.3 M (+0.08 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.37 | 57,270 | 2,941,708 | 45,251,474 | 45.2 M to 45.3 M (+0.13 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.36 | 10,500 | 539,280 | 45,194,204 | 45.2 M to 45.2 M (+0.02 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.30 | 22,700 | 1,164,424 | 45,183,704 | 45.2 M to 45.2 M (+0.05 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.26 | 72,533 | 3,717,693 | 45,161,004 | 45.1 M to 45.2 M (+0.16 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.14 | 100,000 | 5,114,000 | 45,088,471 | 45 M to 45.1 M (+0.22 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 10.08 | 10,000 | 100,800 | 44,988,471 | 45 M to 45 M (+0.02 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 10.08 | 10,000 | 100,800 | 5,288,174 | 5.3 M to 5.3 M (+0.19 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.25 | 168,097 | 8,614,786 | 44,978,471 | 44.8 M to 45 M (+0.38 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.07 | 52,700 | 2,691,173 | 44,810,374 | 44.8 M to 44.8 M (+0.12 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.03 | 248,121 | 12,661,069 | 44,757,674 | 44.5 M to 44.8 M (+0.56 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 50.90 | 154,218 | 7,849,897 | 44,509,553 | 44.4 M to 44.5 M (+0.35 %) |